September 26, 2024

IMS 2024 Myeloma Oral Sessions Day 1

Welcome to the first day of our recap of the latest findings on myeloma treatments reported at the International Myeloma Society (IMS) meeting that kicked off Wednesday in Rio De Janeiro, Brazil. Today gave us important updates on the several treatment combinations for first-line and maintenance therapy for patients with newly diagnosed multiple myeloma (NDMM). […]

September 26, 2024

D-VRd Extends PFS in Newly Diagnosed Multiple Myeloma Subgroups – OncLive

September 25, 2024

Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting

Findings reinforce the value of the MMRF’s integrated clinical and translational research expertise to provide a deeper understanding of multiple myeloma and improve how the disease is treated The MMRF CoMMpassSM Study was cited in 17 abstracts, highlighting how MMRF-led collaborations yield important insights that drive progress in patient care Data on the MMRF’s educational […]

September 23, 2024

Multiple myeloma and spine cancer survivor: ‘Always think about a second opinion’ – MD Anderson Cancer Center

September 23, 2024

Sanofi Secures First-Line Nod for Sarclisa in Multiple Myeloma, Tees Up Competition With J&J – BioSpace